Balance Sheet

Assets

+20%

+42%

10Y

Currency: CNY

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	29	313	322	178	210	215	328	274	762	1 181	582	694	871	757	1 474	2 746	5 382	5 054	5 627	6 141	7 230	8 833	10 873	8 291
Cash	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7 230	8 833	10 040	8 258
Cash Equivalents	29	313	322	178	210	215	328	274	762	1 181	582	694	871	757	1 474	2 746	5 382	5 054	5 627	6 141	0	0	833	33
Short-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11	0	0	0
Total Receivables	181	229	298	343	388	469	668	743	897	968	1 532	1 733	2 136	2 551	2 640	9 195	9 916	10 604	12 334	12 684	13 691	12 945	13 249	14 314
Accounts Receivables	173	226	287	336	382	456	655	720	857	937	1 339	1 603	1 979	2 296	2 226	8 116	9 087	9 836	10 928	5 447	5 712	5 745	8 959	12 336
Other Receivables	8	3	11	7	6	13	13	23	40	31	193	130	157	255	414	1 079	829	768	1 406	7 237	7 979	7 200	4 290	1 978
Inventory	162	200	306	297	262	225	456	412	561	620	761	1 079	964	1 043	1 158	2 658	2 740	3 343	3 356	3 050	3 515	3 717	3 961	4 956
Other Current Assets	9	8	18	21	48	55	77	122	33	81	70	239	146	69	34	294	280	323	359	235	136	268	196	2 796
Total Current Assets	381	749	944	838	908	964	1 528	1 551	2 254	2 849	2 947	3 745	4 117	4 420	5 306	14 894	18 317	19 323	21 676	22 110	24 584	25 764	28 279	30 357
PP&E Net	43	50	131	228	236	233	212	205	215	223	220	388	474	557	583	599	592	637	834	900	846	861	829	887
PP&E Gross	43	50	131	228	236	233	212	205	215	223	220	388	474	557	583	599	592	637	834	900	846	861	829	887
Accumulated Depreciation	26	30	35	30	44	55	63	77	86	97	114	114	156	116	151	250	301	349	428	554	690	777	877	965
Intangible Assets	0	2	3	3	7	7	5	12	10	11	11	72	73	88	94	279	279	287	324	330	326	331	386	392
Goodwill	0	0	0	0	0	0	0	0	0	0	0	2	2	2	2	155	155	158	204	204	204	204	204	204
Long-Term Investments	4	4	4	119	126	169	192	184	251	259	253	261	328	391	484	557	605	919	937	1 144	1 366	1 623	1 925	2 192
Other Long-Term Assets	7	4	6	4	4	28	19	45	46	51	121	91	84	80	86	176	219	186	218	216	685	826	830	897
Other Assets	0	0	0	0	0	0	0	0	0	0	0	2	2	2	2	155	155	158	204	204	204	204	204	204
Total Assets	436 N/A	808 +85%	1 088 +35%	1 193 +10%	1 281 +7%	1 400 +9%	1 956 +40%	1 997 +2%	2 777 +39%	3 393 +22%	3 552 +5%	4 559 +28%	5 079 +11%	5 538 +9%	6 556 +18%	16 660 +154%	20 166 +21%	21 510 +7%	24 194 +12%	24 905 +3%	28 010 +12%	29 609 +6%	32 453 +10%	34 928 +8%
Liabilities
Accounts Payable	149	196	317	340	357	437	674	628	694	966	1 196	1 659	1 618	1 801	1 897	5 796	6 812	7 025	7 780	7 347	8 307	7 372	8 333	8 583
Accrued Liabilities	13	8	10	14	13	26	20	21	24	21	28	36	55	29	35	109	215	231	323	256	362	404	386	362
Short-Term Debt	57	101	146	172	176	171	325	314	593	520	318	551	714	626	607	2 130	2 191	2 116	1 972	2 115	2 180	2 797	2 878	3 988
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	42	70	76	80	74	100
Other Current Liabilities	83	87	94	122	167	116	170	128	51	86	132	265	327	259	347	1 098	1 247	1 254	1 485	1 449	1 814	2 087	2 223	1 822
Total Current Liabilities	301	392	568	647	713	750	1 189	1 091	1 363	1 592	1 673	2 511	2 714	2 715	2 887	9 132	10 465	10 625	11 603	11 237	12 739	12 740	13 894	14 856
Long-Term Debt	0	3	0	5	2	0	0	0	0	0	0	0	0	100	0	0	0	42	167	260	197	183	205	261
Deferred Income Tax	0	0	0	0	0	3	8	4	11	0	0	3	3	3	2	46	43	40	46	41	35	33	27	24
Minority Interest	2	1	36	31	24	36	34	37	40	39	44	74	89	101	485	1 420	1 275	1 377	1 622	1 650	1 575	1 645	1 757	1 847
Other Liabilities	0	0	52	52	44	34	33	33	319	458	346	175	166	139	153	212	202	193	219	273	683	794	794	813
Total Liabilities	303 N/A	397 +31%	655 +65%	735 +12%	783 +7%	824 +5%	1 264 +53%	1 166 -8%	1 734 +49%	2 088 +20%	2 063 -1%	2 764 +34%	2 972 +8%	3 058 +3%	3 526 +15%	10 810 +207%	11 985 +11%	12 277 +2%	13 657 +11%	13 461 -1%	15 230 +13%	15 394 +1%	16 677 +8%	17 800 +7%
Equity
Common Stock	80	133	133	133	133	133	133	239	479	479	479	479	479	479	479	479	767	764	755	755	755	755	755	755
Retained Earnings	10	23	43	78	115	190	288	435	506	768	967	1 274	1 581	1 939	2 404	4 008	5 054	6 113	7 411	8 312	9 652	11 087	12 642	13 997
Additional Paid In Capital	42	242	244	247	250	254	271	157	59	58	43	43	23	27	89	1 312	2 336	2 349	2 349	2 349	2 349	2 349	2 349	2 349
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	25	24	31	27
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10	0	0	0	0	0	0
Other Equity	0	13	13	0	0	0	0	0	0	0	0	0	25	35	58	50	24	16	22	28	0	0	0	0
Total Equity	133 N/A	412 +210%	433 +5%	458 +6%	498 +9%	577 +16%	692 +20%	831 +20%	1 043 +26%	1 304 +25%	1 489 +14%	1 796 +21%	2 107 +17%	2 480 +18%	3 030 +22%	5 849 +93%	8 181 +40%	9 232 +13%	10 537 +14%	11 444 +9%	12 780 +12%	14 215 +11%	15 776 +11%	17 128 +9%
Total Liabilities & Equity	436 N/A	808 +85%	1 088 +35%	1 193 +10%	1 281 +7%	1 400 +9%	1 956 +40%	1 997 +2%	2 777 +39%	3 393 +22%	3 552 +5%	4 559 +28%	5 079 +11%	5 538 +9%	6 556 +18%	16 660 +154%	20 166 +21%	21 510 +7%	24 194 +12%	24 905 +3%	28 010 +12%	29 609 +6%	32 453 +10%	34 928 +8%
Shares Outstanding
Common Shares Outstanding	288	479	479	479	479	479	479	479	479	479	479	479	479	479	479	479	767	764	755	755	755	755	755	755

Income Statement Balance Sheet Cash Flow Statement

China National Medicines Corp Ltd
SSE:600511

Balance Sheet

Balance Sheet Decomposition
China National Medicines Corp Ltd

Balance Sheet
China National Medicines Corp Ltd

See Also

Company

Help

Tools

Stocks

China National Medicines Corp Ltd SSE:600511

Balance Sheet

Balance Sheet Decomposition China National Medicines Corp Ltd

Balance Sheet China National Medicines Corp Ltd

See Also

Company

Help

Tools

Stocks

China National Medicines Corp Ltd
SSE:600511

Balance Sheet Decomposition
China National Medicines Corp Ltd

Balance Sheet
China National Medicines Corp Ltd